The production documents of the Transcutaneous Bilirubinmeter, developed by TÜBİTAK BİLGEM Bioelectronic Systems Department, the device has been made ready for mass production. The device, whose technology transfer process has been completed in line with the trainings and production documents provided, is planned to start mass production and sales activities by AYMED Medikal Inc. in 2022. Thanks to this development, our dependence on foreign countries for the supply of jaundice measurement devices will end.
News
DUHAN BETA Prototype Production Completed
BİLGEM UEKAE Bioelectronic Systems Laboratory carried out a successful study that lasted approximately 12 months for the detection of bioaerosols that pose a danger to human health in the air. Any laboratory work
